Skip to main content
Erschienen in: Neurological Sciences 11/2020

06.05.2020 | Original Article

Association of FLAIR vascular hyperintensity and acute MCA stroke outcome changes with the severity of leukoaraiosis

verfasst von: W. J. Shang, L. M. Shu, X. Zhou, H. Q. Liao, X. H. Chen, H. Hong, H. B. Chen

Erschienen in: Neurological Sciences | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The clinical significance of FLAIR vascular hyperintensity (FVH), a marker of collateral circulation in ischaemic stroke, remains controversial. We hypothesised that the association between FVH and outcomes varies with the severity of leukoaraiosis (LA), another marker of collaterals, and that their combined significance may vary with time.

Methods

We included 459 consecutive patients with middle cerebral artery (MCA) stroke. Proximal and distal FVHs were distinguished based on location. LA was divided into two grades, according to Fazekas scores of 0–2 and 3–6. Symptom-to-MRI time was divided into two categories: ≤ 14 days and ≥ 15 days.

Results

We found no difference in FVH proportion according to LA grade. Multivariate analysis revealed that LA and FVH status were independently associated with unfavourable outcomes (modified Rankin scale ≥ 2) in patients with symptom-to-MRI times ≤ 14 days (P = 0.008), but not in those with symptom-to-MRI times ≥15 days (P = 0.61). In the group with symptom-to-MRI times ≤14 days, patients with LA 3–6 and FVH(+) (OR, 3.044; 95% CI, 1.116–8.305) were more likely to have unfavourable clinical outcomes compared with patients with LA 0–2 and FVH(+) but not compared with those with LA 0–2 and FVH(−) or LA 3–6 and FVH(−). In addition, FVH location did not influence the relationship between FVH and outcomes.

Conclusions

The association between FVH and outcomes was influenced by the degree of LA in the acute but not in the subacute and chronic stages of MCA infarction. FVH predicts clinical outcomes independently only in those with more extensive LA.
Literatur
8.
Zurück zum Zitat Cheng B, Ebinger M, Kufner A, Kohrmann M, Wu O, Kang DW, Liebeskind D, Tourdias T, Singer OC, Christensen S, Warach S, Luby M, Fiebach JB, Fiehler J, Gerloff C, Thomalla G, Stroke Imaging Repository I (2012) Hyperintense vessels on acute stroke fluid-attenuated inversion recovery imaging: associations with clinical and other MRI findings. Stroke 43(11):2957–2961. https://doi.org/10.1161/STROKEAHA.112.658906CrossRefPubMedPubMedCentral Cheng B, Ebinger M, Kufner A, Kohrmann M, Wu O, Kang DW, Liebeskind D, Tourdias T, Singer OC, Christensen S, Warach S, Luby M, Fiebach JB, Fiehler J, Gerloff C, Thomalla G, Stroke Imaging Repository I (2012) Hyperintense vessels on acute stroke fluid-attenuated inversion recovery imaging: associations with clinical and other MRI findings. Stroke 43(11):2957–2961. https://​doi.​org/​10.​1161/​STROKEAHA.​112.​658906CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Karadeli HH, Giurgiutiu DV, Cloonan L, Fitzpatrick K, Kanakis A, Ozcan ME, Schwamm LH, Rost NS (2016) FLAIR vascular hyperintensity is a surrogate of collateral flow and leukoaraiosis in patients with acute stroke due to proximal artery occlusion. J Neuroimaging 26(2):219–223. https://doi.org/10.1111/jon.12274CrossRefPubMed Karadeli HH, Giurgiutiu DV, Cloonan L, Fitzpatrick K, Kanakis A, Ozcan ME, Schwamm LH, Rost NS (2016) FLAIR vascular hyperintensity is a surrogate of collateral flow and leukoaraiosis in patients with acute stroke due to proximal artery occlusion. J Neuroimaging 26(2):219–223. https://​doi.​org/​10.​1111/​jon.​12274CrossRefPubMed
24.
Zurück zum Zitat Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta Stroke Programme Early CT Score Lancet 355(9216):1670–1674PubMed Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta Stroke Programme Early CT Score Lancet 355(9216):1670–1674PubMed
25.
Zurück zum Zitat Uemura A, O'Uchi T, Kikuchi Y, Yashiro N, Ihara N, Shoji K (2004) Prominent laterality of the posterior cerebral artery at three-dimensional time-of-flight MR angiography in M1-segment middle cerebral artery occlusion. AJNR Am J Neuroradiol 25(1):88–91PubMed Uemura A, O'Uchi T, Kikuchi Y, Yashiro N, Ihara N, Shoji K (2004) Prominent laterality of the posterior cerebral artery at three-dimensional time-of-flight MR angiography in M1-segment middle cerebral artery occlusion. AJNR Am J Neuroradiol 25(1):88–91PubMed
26.
Zurück zum Zitat Mantyla R, Pohjasvaara T, Vataja R, Salonen O, Aronen HJ, Standertskjold-Nordenstam CG, Kaste M, Erkinjuntti T (2000) MRI pontine hyperintensity after supratentorial ischemic stroke relates to poor clinical outcome. Stroke 31(3):695–700CrossRef Mantyla R, Pohjasvaara T, Vataja R, Salonen O, Aronen HJ, Standertskjold-Nordenstam CG, Kaste M, Erkinjuntti T (2000) MRI pontine hyperintensity after supratentorial ischemic stroke relates to poor clinical outcome. Stroke 31(3):695–700CrossRef
30.
Zurück zum Zitat Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ (2013) Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Cerebrovasc Dis 35(5):461–468. https://doi.org/10.1159/000350201CrossRefPubMed Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ (2013) Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Cerebrovasc Dis 35(5):461–468. https://​doi.​org/​10.​1159/​000350201CrossRefPubMed
33.
Zurück zum Zitat Nonaka H, Akima M, Hatori T, Nagayama T, Zhang Z, Ihara F (2003) Microvasculature of the human cerebral white matter: arteries of the deep white matter. Neuropathology 23(2):111–118CrossRef Nonaka H, Akima M, Hatori T, Nagayama T, Zhang Z, Ihara F (2003) Microvasculature of the human cerebral white matter: arteries of the deep white matter. Neuropathology 23(2):111–118CrossRef
34.
Zurück zum Zitat Ames A 3rd, Wright RL, Kowada M, Thurston JM, Majno G (1968) Cerebral ischemia. II The no-reflow phenomenon. Am J Pathol 52(2):437–453PubMedPubMedCentral Ames A 3rd, Wright RL, Kowada M, Thurston JM, Majno G (1968) Cerebral ischemia. II The no-reflow phenomenon. Am J Pathol 52(2):437–453PubMedPubMedCentral
37.
Zurück zum Zitat Tomimoto H, Akiguchi I, Ohtani R, Yagi H, Kanda M, Shibasaki H, Yamamoto Y (2001) The coagulation-fibrinolysis system in patients with leukoaraiosis and Binswanger disease. Arch Neurol 58(10):1620–1625CrossRef Tomimoto H, Akiguchi I, Ohtani R, Yagi H, Kanda M, Shibasaki H, Yamamoto Y (2001) The coagulation-fibrinolysis system in patients with leukoaraiosis and Binswanger disease. Arch Neurol 58(10):1620–1625CrossRef
38.
Zurück zum Zitat O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, Markus HS (2002) Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59(3):321–326CrossRef O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, Markus HS (2002) Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59(3):321–326CrossRef
39.
Metadaten
Titel
Association of FLAIR vascular hyperintensity and acute MCA stroke outcome changes with the severity of leukoaraiosis
verfasst von
W. J. Shang
L. M. Shu
X. Zhou
H. Q. Liao
X. H. Chen
H. Hong
H. B. Chen
Publikationsdatum
06.05.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 11/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04411-8

Weitere Artikel der Ausgabe 11/2020

Neurological Sciences 11/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.